FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ: MSON), a developer of minimally invasive ultrasonic medical device technology, which, in Europe is used for the ablation of cancer and worldwide for other acute health conditions, today announced that its Sonora Medical Systems subsidiary (“Sonora Medical”) has received multiple sales awards for its advanced design Acoustic Power and Intensity (“API”) Testing Suite from major medical device testing entities on a worldwide basis. Sonora Medical received orders totaling approximately $300,000 from the Polish Academy of Sciences, the National Institute of Metrology, Standardization and Industrial Quality in Brazil, the Korea Testing Laboratory and the China National Metrology laboratory.
